[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Monoclonal antibodies (mAbs) Biosimilars Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect

January 2024 | 98 pages | ID: G32069DEF8B4EN
Maia Research

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Monoclonal antibodies (mAbs) Biosimilars market covering all its essential aspects.

For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.

In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.

Key players in the global Monoclonal antibodies (mAbs) Biosimilars market are covered in Chapter 9:

AET Biotech

3SBio

Celltrion

Dr. Reddy's Laboratories

Hospira

Accord Healthcare

Amega Biotech

Biocon

Allergan

In Chapter 5 and Chapter 7.3, based on types, the Monoclonal antibodies (mAbs) Biosimilars market from 2017 to 2027 is primarily split into:

Erythropoietin (EPO)

Human Growth Hormone (HGH)

Granulocyte- Colony Stimulating Factor (G-CSF)

Monoclonal Antibody (mAb)

Insulin

Interferon (IFN)

Others

In Chapter 6 and Chapter 7.4, based on applications, the Monoclonal antibodies (mAbs) Biosimilars market from 2017 to 2027 covers:

Anti-Cancer

Anti-Inflammatory/Autoimmune

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:

United States

Europe

China

Japan

India

Southeast Asia

Latin America

Middle East and Africa

Client Focus

1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Monoclonal antibodies (mAbs) Biosimilars market?

Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Monoclonal antibodies (mAbs) Biosimilars Industry.

2. How do you determine the list of the key players included in the report?

With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.

Please find the key player list in Summary.

3. What are your main data sources?

Both Primary and Secondary data sources are being used while compiling the report.

Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.

Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.

Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.

4. Can I modify the scope of the report and customize it to suit my requirements?

Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.

Outline

Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.

Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.

Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.

Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.

Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.

Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.

Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.

Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.

Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.

Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.

Chapter 11 introduces the market research methods and data sources.

Years considered for this report:

Historical Years: 2017-2021

Base Year: 2021

Estimated Year: 2022

Forecast Period: 2022-2027
1 MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Monoclonal antibodies (mAbs) Biosimilars Market
1.2 Monoclonal antibodies (mAbs) Biosimilars Market Segment by Type
  1.2.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Monoclonal antibodies (mAbs) Biosimilars Market Segment by Application
  1.3.1 Monoclonal antibodies (mAbs) Biosimilars Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Monoclonal antibodies (mAbs) Biosimilars Market, Region Wise (2017-2027)
  1.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
  1.4.2 United States Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.3 Europe Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.4 China Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.5 Japan Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.6 India Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.7 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.8 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
  1.4.9 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Status and Prospect (2017-2027)
1.5 Global Market Size of Monoclonal antibodies (mAbs) Biosimilars (2017-2027)
  1.5.1 Global Monoclonal antibodies (mAbs) Biosimilars Market Revenue Status and Outlook (2017-2027)
  1.5.2 Global Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Monoclonal antibodies (mAbs) Biosimilars Market

2 INDUSTRY OUTLOOK

2.1 Monoclonal antibodies (mAbs) Biosimilars Industry Technology Status and Trends
2.2 Industry Entry Barriers
  2.2.1 Analysis of Financial Barriers
  2.2.2 Analysis of Technical Barriers
  2.2.3 Analysis of Talent Barriers
  2.2.4 Analysis of Brand Barrier
2.3 Monoclonal antibodies (mAbs) Biosimilars Market Drivers Analysis
2.4 Monoclonal antibodies (mAbs) Biosimilars Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Monoclonal antibodies (mAbs) Biosimilars Industry Development Trends under COVID-19 Outbreak
  2.7.1 Global COVID-19 Status Overview
  2.7.2 Influence of COVID-19 Outbreak on Monoclonal antibodies (mAbs) Biosimilars Industry Development

3 GLOBAL MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS MARKET LANDSCAPE BY PLAYER

3.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Share by Player (2017-2022)
3.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Player (2017-2022)
3.3 Global Monoclonal antibodies (mAbs) Biosimilars Average Price by Player (2017-2022)
3.4 Global Monoclonal antibodies (mAbs) Biosimilars Gross Margin by Player (2017-2022)
3.5 Monoclonal antibodies (mAbs) Biosimilars Market Competitive Situation and Trends
  3.5.1 Monoclonal antibodies (mAbs) Biosimilars Market Concentration Rate
  3.5.2 Monoclonal antibodies (mAbs) Biosimilars Market Share of Top 3 and Top 6 Players
  3.5.3 Mergers & Acquisitions, Expansion

4 GLOBAL MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS SALES VOLUME AND REVENUE REGION WISE (2017-2022)

4.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.4.1 United States Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.5 Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.5.1 Europe Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.6 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.6.1 China Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.7 Japan Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.7.1 Japan Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.8 India Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.8.1 India Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.9 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.9.1 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.10 Latin America Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.10.1 Latin America Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19
4.11 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue, Price and Gross Margin (2017-2022)
  4.11.1 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Under COVID-19

5 GLOBAL MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS SALES VOLUME, REVENUE, PRICE TREND BY TYPE

5.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Market Share by Type (2017-2022)
5.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Market Share by Type (2017-2022)
5.3 Global Monoclonal antibodies (mAbs) Biosimilars Price by Type (2017-2022)
5.4 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate by Type (2017-2022)
  5.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Erythropoietin (EPO) (2017-2022)
  5.4.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Human Growth Hormone (HGH) (2017-2022)
  5.4.3 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2017-2022)
  5.4.4 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Monoclonal Antibody (mAb) (2017-2022)
  5.4.5 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Insulin (2017-2022)
  5.4.6 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Interferon (IFN) (2017-2022)
  5.4.7 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Growth Rate of Others (2017-2022)

6 GLOBAL MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS MARKET ANALYSIS BY APPLICATION

6.1 Global Monoclonal antibodies (mAbs) Biosimilars Consumption and Market Share by Application (2017-2022)
6.2 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Monoclonal antibodies (mAbs) Biosimilars Consumption and Growth Rate by Application (2017-2022)
  6.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Consumption and Growth Rate of Anti-Cancer (2017-2022)
  6.3.2 Global Monoclonal antibodies (mAbs) Biosimilars Consumption and Growth Rate of Anti-Inflammatory/Autoimmune (2017-2022)

7 GLOBAL MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS MARKET FORECAST (2022-2027)

7.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue Forecast (2022-2027)
  7.1.1 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate Forecast (2022-2027)
  7.1.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate Forecast (2022-2027)
  7.1.3 Global Monoclonal antibodies (mAbs) Biosimilars Price and Trend Forecast (2022-2027)
7.2 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast, Region Wise (2022-2027)
  7.2.1 United States Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.2 Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.3 China Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.4 Japan Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.5 India Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.6 Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.7 Latin America Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
  7.2.8 Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue and Price Forecast by Type (2022-2027)
  7.3.1 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Erythropoietin (EPO) (2022-2027)
  7.3.2 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Human Growth Hormone (HGH) (2022-2027)
  7.3.3 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2022-2027)
  7.3.4 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Monoclonal Antibody (mAb) (2022-2027)
  7.3.5 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Insulin (2022-2027)
  7.3.6 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Interferon (IFN) (2022-2027)
  7.3.7 Global Monoclonal antibodies (mAbs) Biosimilars Revenue and Growth Rate of Others (2022-2027)
7.4 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Forecast by Application (2022-2027)
  7.4.1 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Value and Growth Rate of Anti-Cancer(2022-2027)
  7.4.2 Global Monoclonal antibodies (mAbs) Biosimilars Consumption Value and Growth Rate of Anti-Inflammatory/Autoimmune(2022-2027)
7.5 Monoclonal antibodies (mAbs) Biosimilars Market Forecast Under COVID-19

8 MONOCLONAL ANTIBODIES (MABS) BIOSIMILARS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS

8.1 Monoclonal antibodies (mAbs) Biosimilars Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
  8.3.1 Labor Cost Analysis
  8.3.2 Energy Costs Analysis
  8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Monoclonal antibodies (mAbs) Biosimilars Analysis
8.6 Major Downstream Buyers of Monoclonal antibodies (mAbs) Biosimilars Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Monoclonal antibodies (mAbs) Biosimilars Industry

9 PLAYERS PROFILES

9.1 AET Biotech
  9.1.1 AET Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.1.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.1.3 AET Biotech Market Performance (2017-2022)
  9.1.4 Recent Development
  9.1.5 SWOT Analysis
9.2 3SBio
  9.2.1 3SBio Basic Information, Manufacturing Base, Sales Region and Competitors
  9.2.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.2.3 3SBio Market Performance (2017-2022)
  9.2.4 Recent Development
  9.2.5 SWOT Analysis
9.3 Celltrion
  9.3.1 Celltrion Basic Information, Manufacturing Base, Sales Region and Competitors
  9.3.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.3.3 Celltrion Market Performance (2017-2022)
  9.3.4 Recent Development
  9.3.5 SWOT Analysis
9.4 Dr. Reddy's Laboratories
  9.4.1 Dr. Reddy's Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
  9.4.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.4.3 Dr. Reddy's Laboratories Market Performance (2017-2022)
  9.4.4 Recent Development
  9.4.5 SWOT Analysis
9.5 Hospira
  9.5.1 Hospira Basic Information, Manufacturing Base, Sales Region and Competitors
  9.5.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.5.3 Hospira Market Performance (2017-2022)
  9.5.4 Recent Development
  9.5.5 SWOT Analysis
9.6 Accord Healthcare
  9.6.1 Accord Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
  9.6.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.6.3 Accord Healthcare Market Performance (2017-2022)
  9.6.4 Recent Development
  9.6.5 SWOT Analysis
9.7 Amega Biotech
  9.7.1 Amega Biotech Basic Information, Manufacturing Base, Sales Region and Competitors
  9.7.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.7.3 Amega Biotech Market Performance (2017-2022)
  9.7.4 Recent Development
  9.7.5 SWOT Analysis
9.8 Biocon
  9.8.1 Biocon Basic Information, Manufacturing Base, Sales Region and Competitors
  9.8.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.8.3 Biocon Market Performance (2017-2022)
  9.8.4 Recent Development
  9.8.5 SWOT Analysis
9.9 Allergan
  9.9.1 Allergan Basic Information, Manufacturing Base, Sales Region and Competitors
  9.9.2 Monoclonal antibodies (mAbs) Biosimilars Product Profiles, Application and Specification
  9.9.3 Allergan Market Performance (2017-2022)
  9.9.4 Recent Development
  9.9.5 SWOT Analysis

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Data Source

LIST OF TABLES AND FIGURES




Figure Monoclonal antibodies (mAbs) Biosimilars Product Picture

Table Global Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and CAGR (%) Comparison by Type

Table Monoclonal antibodies (mAbs) Biosimilars Market Consumption (Sales Volume) Comparison by Application (2017-2027)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)

Figure United States Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Europe Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure China Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Japan Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure India Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Latin America Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate (2017-2027)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume Status and Outlook (2017-2027)

Table Global Macroeconomic Analysis

Figure Global COVID-19 Status Overview

Table Influence of COVID-19 Outbreak on Monoclonal antibodies (mAbs) Biosimilars Industry Development

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume by Player (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share by Player (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Share by Player in 2021

Table Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) by Player (2017-2022)

Table Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Player (2017-2022)

Table Monoclonal antibodies (mAbs) Biosimilars Price by Player (2017-2022)

Table Monoclonal antibodies (mAbs) Biosimilars Gross Margin by Player (2017-2022)

Table Mergers & Acquisitions, Expansion Plans

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Region Wise (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Market Share, Region Wise (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Market Share, Region Wise in 2021

Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD), Region Wise (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, Region Wise (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, Region Wise (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share, Region Wise in 2021

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table United States Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Europe Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table China Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Japan Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table India Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Latin America Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume by Type (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Market Share by Type (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Market Share by Type in 2021

Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) by Type (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share by Type in 2021

Table Monoclonal antibodies (mAbs) Biosimilars Price by Type (2017-2022)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Erythropoietin (EPO) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Erythropoietin (EPO) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Human Growth Hormone (HGH) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Human Growth Hormone (HGH) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Monoclonal Antibody (mAb) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibody (mAb) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Insulin (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Insulin (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Interferon (IFN) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Interferon (IFN) (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate of Others (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Others (2017-2022)
Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption by Application (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption Market Share by Application (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption Revenue (Million USD) by Application (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption Revenue Market Share by Application (2017-2022)

Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption and Growth Rate of Anti-Cancer (2017-2022)
Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption and Growth Rate of Anti-Inflammatory/Autoimmune (2017-2022)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate Forecast (2022-2027)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate Forecast (2022-2027)

Figure Global Monoclonal antibodies (mAbs) Biosimilars Price and Trend Forecast (2022-2027)

Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure USA Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Europe Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure China Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure China Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Japan Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure India Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure India Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Southeast Asia Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Latin America Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)

Figure Middle East and Africa Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)

Table Global Monoclonal antibodies (mAbs) Biosimilars Market Sales Volume Forecast, by Type

Table Global Monoclonal antibodies (mAbs) Biosimilars Sales Volume Market Share Forecast, by Type

Table Global Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) Forecast, by Type

Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share Forecast, by Type

Table Global Monoclonal antibodies (mAbs) Biosimilars Price Forecast, by Type

Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Erythropoietin (EPO) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Erythropoietin (EPO) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Human Growth Hormone (HGH) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Human Growth Hormone (HGH) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Granulocyte- Colony Stimulating Factor (G-CSF) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibody (mAb) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Monoclonal Antibody (mAb) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Insulin (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Interferon (IFN) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Interferon (IFN) (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Others (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Revenue (Million USD) and Growth Rate of Others (2022-2027)
Table Global Monoclonal antibodies (mAbs) Biosimilars Market Consumption Forecast, by Application

Table Global Monoclonal antibodies (mAbs) Biosimilars Consumption Market Share Forecast, by Application

Table Global Monoclonal antibodies (mAbs) Biosimilars Market Revenue (Million USD) Forecast, by Application

Table Global Monoclonal antibodies (mAbs) Biosimilars Revenue Market Share Forecast, by Application

Figure Global Monoclonal antibodies (mAbs) Biosimilars Consumption Value (Million USD) and Growth Rate of Anti-Cancer (2022-2027)
Figure Global Monoclonal antibodies (mAbs) Biosimilars Consumption Value (Million USD) and Growth Rate of Anti-Inflammatory/Autoimmune (2022-2027)
Figure Monoclonal antibodies (mAbs) Biosimilars Industrial Chain Analysis

Table Key Raw Materials Suppliers and Price Analysis

Figure Manufacturing Cost Structure Analysis

Table Alternative Product Analysis

Table Downstream Distributors

Table Downstream Buyers

Table AET Biotech Profile
Table AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AET Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure AET Biotech Revenue (Million USD) Market Share 2017-2022
Table 3SBio Profile
Table 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure 3SBio Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure 3SBio Revenue (Million USD) Market Share 2017-2022
Table Celltrion Profile
Table Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celltrion Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Celltrion Revenue (Million USD) Market Share 2017-2022
Table Dr. Reddy's Laboratories Profile
Table Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dr. Reddy's Laboratories Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Dr. Reddy's Laboratories Revenue (Million USD) Market Share 2017-2022
Table Hospira Profile
Table Hospira Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Hospira Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Hospira Revenue (Million USD) Market Share 2017-2022
Table Accord Healthcare Profile
Table Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Accord Healthcare Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Accord Healthcare Revenue (Million USD) Market Share 2017-2022
Table Amega Biotech Profile
Table Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Amega Biotech Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Amega Biotech Revenue (Million USD) Market Share 2017-2022
Table Biocon Profile
Table Biocon Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biocon Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Biocon Revenue (Million USD) Market Share 2017-2022
Table Allergan Profile
Table Allergan Monoclonal antibodies (mAbs) Biosimilars Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Allergan Monoclonal antibodies (mAbs) Biosimilars Sales Volume and Growth Rate
Figure Allergan Revenue (Million USD) Market Share 2017-2022






More Publications